The Bank of Nova Scotia
BNSThe Bank of Nova Scotia's price has outrun its earnings. +57.2% in a year against EPS −3.4% — the market is paying now for delivery later.
The sharpest disagreement: the price moved +57.2% in a year while annual EPS moved −3.4% — the difference is re-rating, and re-rating has to be repaid with earnings.
The price is in a confirmed uptrend (65 weeks in) while the P/BV sits at the 100th percentile of its own 5-year range. Underneath, the last four quarters read improving — profit +29.6% year on year, with the the net margin at 30.5%. What settles it: whether earnings grow into a price that has already moved.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
The Bank of Nova Scotia trades at $87.1, in a confirmed uptrend and 65 weeks into that stage. That is +15.4% against its own 200-day average. It sits at 93% of a 52-week range of $57 to $89. On relative strength it has been ahead of the S&P 500 on a trailing-13-week view for 10 straight weeks.
Today the stock is in a confirmed uptrend — week 65 of stage 2. At $87.1 it trades +15.4% versus its 200-day average and sits at 93% of its 52-week range ($57–$89).
Against the market, two honest reads. Cumulative: over the last 10.1 years the stock moved +79% while the S&P 500 moved +263% — behind the index over the full window. Recent form: on a trailing-13-week view the stock has been ahead for 10 straight weeks — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
Valuation For a bank we price the book, not the earnings: P/BV is what the market pays for each $1 of the bank's net worth. A bank below 1× book is priced below the value of what it owns, net of what it owes.
The Bank of Nova Scotia trades at 1.6× P/BV, about the priciest it has ever traded. Its long-run median P/BV is 0.8×, measured across 5.0 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.
Today's P/BV of 1.6× is about the priciest it has ever traded, against a long-run median of 0.8× measured over 5.0 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.
The honest context for that discount: a bank earning about 11% on its equity is worth less per dollar of book, and the market has priced that in rather than overlooked it. The discount closes only if the returns themselves improve.
🚨 Why the multiple sits where it does: over the past year book value grew while the price moved +57.2% — the price ran ahead of the book, pushing the multiple up its own range.
The price move, decomposed: over 5y, of the +6.6%/yr price move, ~+4.3%/yr came from book-value growth and ~+2.3 pp from the multiple (expanding). The split is the honest approximate (price return minus book-value growth); it makes the rally itself visible instead of hiding it behind the percentile.
Put together: the multiple is full against its own past, so the story rests on the book-value line underneath it, not the multiple.
Stage: Mixed Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
The Bank of Nova Scotia reads as mixed on its fundamental arc. Mixed — no clean majority across the growth curves, ROE lifting at 10.9% — the per-curve reads carry the story. The read is built from 12 quarters across 4 curves, on full evidence.
Why it matters: when the curves disagree, the per-curve reads above matter more than any single verdict.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Revenue | +11.5% | +3.2% | — | — |
| Profit | −1.6% | −8.6% | — | — |
| EPS | −3.4% | −10.9% | — | — |
| Stock price | +57.2% | +21.9% | +6.6% | +5.6% |
4-Factor Sector Score
44.2/100 — rank 9 of 18 in Banks - Diversified · 64% evidence confidence
The Bank of Nova Scotia scores 44.2 out of 100 against the 18 companies it is compared with in Banks - Diversified, ranking 9. Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -3.1% and the one-year return is 55.6%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth.
The four contributions add to the total exactly: 22.8 + 10.4 + 5.6 + 5.4 = 44.2. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if ROA rolls over or gross NPA rises while sector-relative strength deteriorates.
Revenue For a bank, revenue is everything the franchise earns — interest on the loan book plus fees from its businesses.
The Bank of Nova Scotia reported $8.6 B of income in the Apr 26 quarter, +12.2% year on year. That is the 10th straight quarter of year-on-year growth. Over 4 years it has compounded at 2.9% a year. The last full year, FY25, came in at $33.0 B. The last four reported quarters add to $34.2 B.
FY25 revenue came in at $33.0 B (+11.5% on the year), capping 4 years at 2.9% compound. The latest quarter (Apr 26) printed $8.6 B, +12.2% year on year — the 10th consecutive quarter of year-over-year growth.
Pace check: the last four quarters averaged +11.7% growth against the decade's 2.9% — the current year is running faster than its own long-run rate.
Acceleration check: trailing-twelve-month revenue grew +11.5% over the last 4 quarters against +8.5%/yr over the last 8 — stabilising; TTM profit +46.1% vs +11.1%/yr — accelerating.
Net margin Net margin — what the bank keeps of every $100 of revenue after every cost, provision and tax. With big fee businesses in the mix, it is the cleanest margin we can read for this bank.
The Bank of Nova Scotia's net margin is 30.5% in the Apr 26 quarter, +4.1 percentage points against the same quarter a year ago. Across 5 fiscal years the net margin has ranged 23.5% to 33.9%. The current quarter sits inside that band.
The latest quarter's net margin is 30.5%, +4.1 pp against the same quarter a year ago. Across 5 fiscal years the net margin has ranged 23.5%–33.9%.
Why: the numbers show the net margin move clearly, but the cost lines behind it sit below what we hold — so we state the move without inventing its driver.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
The Bank of Nova Scotia earned $2.6 B of net profit in the Apr 26 quarter, +29.6% year on year. It is the 4th consecutive quarter of growth. Full-year FY25 profit was $7.8 B. The 4-year compound rate is −6.0%. That is 30.5% of the quarter's revenue. The same quarter a year earlier earned $2.0 B.
Apr 26 profit was $2.6 B, +29.6% year on year — the 4th consecutive quarter of growth. On the full year, FY25 printed $7.8 B (−1.6%), and the 4-year compound rate is −6.0%.
Why profit moved: revenue contributed +12.2% and the margin +4.1 pp — the quarter was margin-led: most of the profit growth came from keeping more of each sale.
Pace comparison, last four quarters: profit +56.3% vs revenue +11.7%. Profit is growing faster than sales — fixed costs are being spread over a bigger base, and each extra dollar of revenue drops more to the bottom line.
Asset quality — the ladder Gross NPA is the slice of the loan book where repayments have stopped. Net NPA is what remains after the money already set aside against those loans. Falling is healing; rising is damage arriving.
Loan-book quality history is not available for The Bank of Nova Scotia, so this section names the gap rather than estimating a ratio. No gross or net non-performing-asset series is filed in a form this page can read, and none is inferred from the profit line. The income, margin and return sections above carry the evidence this business does report.
We do not hold quarterly loan-book quality numbers for this bank, so this section states that plainly rather than working around it.
Why: loan-book quality is the engine room of a bank, and its drivers — slippages, recoveries, provisioning — sit below what we hold for this name; the sections around it carry the reads we can stand behind.
The loan book We read the loan book through revenue — when the book and the businesses grow, revenue grows with them. It is a rough proxy, and we say so: rate moves and fee swings can shift it a few points in any one year.
The Bank of Nova Scotia's revenue grew +11.5% in FY25 to $33.0 B, so the book is growing. The latest quarter ran +12.2% year on year. The net margin on that income is 30.5%, +4.1 percentage points against a year ago.
FY25 revenue was $33.0 B, +11.5% on the year, and the latest quarter ran +12.2% year on year. The net margin on that revenue is 30.5% this quarter (+4.1 pp YoY) — growth with a widening margin on it.
The synthesis: a lender compounds when the book grows while the margin holds and the loan book stays clean — with quarterly loan-quality numbers missing here, revenue growth and margin are the two we watch.
Returns on equity and assets Two numbers rate a bank: ROE — what it earns on shareholder money — and ROA — what it earns on everything it deploys. ROE above ~13–15% earns its keep; below that, growth builds book slowly.
The Bank of Nova Scotia earns a return on equity of 9% in FY25. Its trough over the ladder below was 9% in FY25. On the asset side every $100 of the balance sheet earned about $0.66, which is the return before leverage is applied.
FY25 ROE came in at 9%. On assets, the latest reading is about 0.66% — every $100 the bank deploys earns roughly $0.66 a year. That return is below the bar a bank must clear to compound book value quickly — which is also the honest reason the stock trades where it does.
Why: the ROE ladder shows the move; the deposit-cost and provisioning drivers behind it sit below what we hold.
Dividend A dividend is cash paid out per share. Dividend per share is the declared amount for the period; the trailing twelve-month total is the four most recent quarters added together.
The Bank of Nova Scotia paid $4.40 per share over the last four reported quarters, up 3.8% on a year ago. The most recent declaration was $1.10 for Apr 26. Against the current price of $87.1 that is a trailing yield of 5.05%, measured on dividends already paid rather than on a forecast.
The Bank of Nova Scotia paid $4.40 per share across the last four reported quarters, most recently $1.10 for Apr 26. That is up 3.8% against the same quarter a year earlier. Against the current price of $87.1 the trailing twelve months work out to 5.05% — trailing dividends measured against today's price, not a forward estimate.
Debt
For a bank, borrowings are raw material, not a warning sign — solvency is read through the returns and the loan book. A manufacturer’s debt is a claim against its profits, so the debt-to-equity lens that works everywhere else misleads on a lender and is not applied here.
A manufacturer’s debt is a claim against its profits; a bank’s borrowings are its inventory — money taken in to be lent out. The debt lens that works everywhere else misleads here, so this page does not apply it. The solvency questions for a bank — is the loan book sound, is the equity earning — are read through the loan-book and returns sections above.
Ownership There is no quarter-by-quarter holder register to read here, so we read the crowd through short interest — the slice of tradable shares currently sold short, positioned for a fall.
0.7% of The Bank of Nova Scotia's tradable float is currently sold short — the crowd is not positioned against this stock. At typical trading volumes those positions would take about 3.5 days to buy back. There is no quarter-by-quarter holder register to read for this filer, so the crowd is read through short interest instead.
The latest reading: 0.7% of the float is sold short, and at typical trading volumes it would take about 3.5 days to buy those positions back. The crowd is not positioned against this stock. This is a single point-in-time reading — we do not yet hold its history, so we show no trend chart.
Why it sits there: who is doing the shorting, and why, does not travel with the number — the level is shown without inventing its story.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
The Bank of Nova Scotia: the Z-score is omitted — it was built for manufacturers, not banks, and applying it here would be theatre. The Z-score was built for manufacturers and is not applied to banks and lenders, so solvency here is read from the capital and asset-quality lines instead.
The safety line in one sentence: the Z-score is omitted — it was built for manufacturers, not banks, and applying it here would be theatre.
| Company | Score | Price stage | Growth & earnings/35 | Capital efficiency/25 | Valuation/20 | Relative strength/20 |
|---|---|---|---|---|---|---|
| 1Bank of MontrealBMO | 50.9/100Mixed-positive evidence64% evidence | BREAKING OUT | 20.2/35 Income 13.3% · PAT 17.8% 62% evidence | 11.0/25 ROA — · ROE 3.1% · GNPA — 34% evidence | 4.7/20 P/BV 1.69× · P/BV÷ROE 0.55 70% evidence | 15.0/20 RS sector 3.1% · RS bench 13.7% · 1Y 59.3%10 of 12 weeks ahead 100% evidence |
| Exact sum: 20.2 + 11 + 4.7 + 15 = 50.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 2The Bank of New York Mellon CorporationBNY | 49.1/100Mixed-negative evidence60% evidence | LEADER | 18.4/35 Income — · PAT — 26% evidence | 8.8/25 ROA 0.4% · ROE 4% · GNPA — 68% evidence | 4.9/20 P/BV 2.11× · P/BV÷ROE 0.53 70% evidence | 17.0/20 RS sector 4.1% · RS bench 14.8% · 1Y 52.1%12 of 12 weeks ahead 100% evidence |
| Exact sum: 18.4 + 8.8 + 4.9 + 17 = 49.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 3Bank of America CorporationBAC | 48.9/100Mixed-negative evidence64% evidence | BREAKING OUT | 22.8/35 Income 15.3% · PAT 19.4% 62% evidence | 10.4/25 ROA — · ROE 3% · GNPA — 34% evidence | 6.5/20 P/BV 1.34× · P/BV÷ROE 0.45 70% evidence | 9.2/20 RS sector -4.1% · RS bench 6.3% · 1Y 36.7%7 of 12 weeks ahead 100% evidence |
| Exact sum: 22.8 + 10.4 + 6.5 + 9.2 = 48.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 4JPMorgan Chase & Co.JPM | 48.5/100Mixed-negative evidence64% evidence | TURNING | 20.7/35 Income 13.8% · PAT 15.1% 62% evidence | 13.9/25 ROA — · ROE 5.8% · GNPA — 34% evidence | 6.4/20 P/BV 2.34× · P/BV÷ROE 0.4 70% evidence | 7.5/20 RS sector -7% · RS bench 3.1% · 1Y 23.8%4 of 12 weeks ahead 100% evidence |
| Exact sum: 20.7 + 13.9 + 6.4 + 7.5 = 48.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 5Canadian Imperial Bank of CommerceCM | 48.1/100Mixed-negative evidence64% evidence | BREAKING OUT | 23.3/35 Income 13.6% · PAT 25.3% 62% evidence | 12.7/25 ROA — · ROE 3.9% · GNPA — 34% evidence | 4.5/20 P/BV 2.11× · P/BV÷ROE 0.54 70% evidence | 7.6/20 RS sector -0.1% · RS bench 10.1% · 1Y 62.4%4 of 12 weeks ahead 100% evidence |
| Exact sum: 23.3 + 12.7 + 4.5 + 7.6 = 48.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 6HSBC Holdings plcHSBC | 47.9/100Mixed-negative evidence62% evidence | TURNING | 12.0/35 Income 7.6% · PAT 5.6% 55% evidence | 12.2/25 ROA — · ROE 3.7% · GNPA — 34% evidence | 7.4/20 P/BV 1.44× · P/BV÷ROE 0.39 70% evidence | 16.3/20 RS sector 5.5% · RS bench 16.2% · 1Y 66.4%5 of 12 weeks ahead 100% evidence |
| Exact sum: 12 + 12.2 + 7.4 + 16.3 = 47.9 · Decision use: Price leads the evidence: RS versus the benchmark is 16.2%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 7Royal Bank of CanadaRY | 47.2/100Mixed-negative evidence64% evidence | BREAKING OUT | 20.8/35 Income 13% · PAT 21.5% 62% evidence | 13.1/25 ROA — · ROE 4% · GNPA — 34% evidence | 3.0/20 P/BV 2.41× · P/BV÷ROE 0.6 70% evidence | 10.3/20 RS sector 0.4% · RS bench 10.7% · 1Y 57.3%10 of 12 weeks ahead 100% evidence |
| Exact sum: 20.8 + 13.1 + 3 + 10.3 = 47.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 8Citigroup Inc.C | 45.4/100Mixed-negative evidence64% evidence | TURNING | 23.3/35 Income 12.9% · PAT 27.8% 62% evidence | 9.2/25 ROA — · ROE 2.8% · GNPA — 34% evidence | 8.6/20 P/BV 0.59× · P/BV÷ROE 0.21 70% evidence | 4.3/20 RS sector -3.1% · RS bench 6.9% · 1Y 47.6%5 of 12 weeks ahead 100% evidence |
| Exact sum: 23.3 + 9.2 + 8.6 + 4.3 = 45.4 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -3.1% and the one-year return is 47.6%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth. | ||||||
| 9The Bank of Nova Scotiathis pageBNS | 44.2/100Mixed-negative evidence64% evidence | BREAKING OUT | 22.8/35 Income 11.5% · PAT 45.9% 62% evidence | 10.4/25 ROA — · ROE 3% · GNPA — 34% evidence | 5.6/20 P/BV 1.49× · P/BV÷ROE 0.5 70% evidence | 5.4/20 RS sector -3.1% · RS bench 7% · 1Y 55.6%9 of 12 weeks ahead 100% evidence |
| Exact sum: 22.8 + 10.4 + 5.6 + 5.4 = 44.2 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -3.1% and the one-year return is 55.6%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth. | ||||||
| 10Wells Fargo & CompanyWFC | 38.5/100Mixed-negative evidence64% evidence | TURNING | 13.1/35 Income 7% · PAT 10.6% 62% evidence | 11.9/25 ROA — · ROE 3.6% · GNPA — 34% evidence | 7.7/20 P/BV 1.39× · P/BV÷ROE 0.39 70% evidence | 5.8/20 RS sector -15.1% · RS bench -5.8% · 1Y 13.5%2 of 12 weeks ahead 100% evidence |
| Exact sum: 13.1 + 11.9 + 7.7 + 5.8 = 38.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 11The Toronto-Dominion BankTD | 31.8/100Adverse evidence64% evidence | LEADER | 6.6/35 Income -4.5% · PAT -10.7% 62% evidence | 10.9/25 ROA — · ROE 3.4% · GNPA — 34% evidence | 3.9/20 P/BV 1.94× · P/BV÷ROE 0.57 70% evidence | 10.4/20 RS sector 1.7% · RS bench 12% · 1Y 63%12 of 12 weeks ahead 100% evidence |
| Exact sum: 6.6 + 10.9 + 3.9 + 10.4 = 31.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 12Banco Bilbao Vizcaya Argentaria, S.A.BBVA | 56.6/100Thin evidence · provisional46% evidence | BREAKING OUT | 17.1/35 Income — · PAT — 10% evidence | 13.7/25 ROA — · ROE 5.3% · GNPA — 34% evidence | 8.6/20 P/BV 1.62× · P/BV÷ROE 0.31 70% evidence | 17.2/20 RS sector 3.1% · RS bench 13.8% · 1Y 51.3%3 of 12 weeks ahead 100% evidence |
| Exact sum: 17.1 + 13.7 + 8.6 + 17.2 = 56.6 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 13ING Groep N.V.ING | 51.3/100Thin evidence · provisional46% evidence | BREAKING OUT | 17.5/35 Income — · PAT — 10% evidence | 12.4/25 ROA — · ROE 3.8% · GNPA — 34% evidence | 6.8/20 P/BV 1.56× · P/BV÷ROE 0.41 70% evidence | 14.6/20 RS sector 3% · RS bench 13.7% · 1Y 44.6%8 of 12 weeks ahead 100% evidence |
| Exact sum: 17.5 + 12.4 + 6.8 + 14.6 = 51.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 14Forbright, Inc.FRBT | 47.6/100Thin evidence · provisional10% evidence | 18.0/35 Income — · PAT — 3% evidence | 9.6/25 ROA — · ROE 0.9% · GNPA — 34% evidence | 10.0/20 P/BV — · P/BV÷ROE — 0% evidence | 10.0/20 RS sector — · RS bench — · 1Y — 0% evidence | |
| Exact sum: 18 + 9.6 + 10 + 10 = 47.6 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 15Banco Santander, S.A.SAN | 46.6/100Thin evidence · provisional46% evidence | BREAKING OUT | 16.7/35 Income — · PAT — 10% evidence | 11.4/25 ROA — · ROE 3.3% · GNPA — 34% evidence | 6.2/20 P/BV 1.58× · P/BV÷ROE 0.48 70% evidence | 12.3/20 RS sector 1.6% · RS bench 12.1% · 1Y 55.4%7 of 12 weeks ahead 100% evidence |
| Exact sum: 16.7 + 11.4 + 6.2 + 12.3 = 46.6 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 16Barclays PLCBCS | 45.3/100Thin evidence · provisional46% evidence | BREAKING OUT | 17.1/35 Income — · PAT — 10% evidence | 10.4/25 ROA — · ROE 3% · GNPA — 34% evidence | 8.1/20 P/BV 1.04× · P/BV÷ROE 0.34 70% evidence | 9.7/20 RS sector -3% · RS bench 7.1% · 1Y 40.5%8 of 12 weeks ahead 100% evidence |
| Exact sum: 17.1 + 10.4 + 8.1 + 9.7 = 45.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 17UBS Group AGUBS | 42.9/100Thin evidence · provisional46% evidence | LEADER | 16.9/35 Income — · PAT — 10% evidence | 10.1/25 ROA — · ROE 3.1% · GNPA — 34% evidence | 4.3/20 P/BV 1.7× · P/BV÷ROE 0.55 70% evidence | 11.6/20 RS sector -0.2% · RS bench 10.3% · 1Y 35.2%10 of 12 weeks ahead 100% evidence |
| Exact sum: 16.9 + 10.1 + 4.3 + 11.6 = 42.9 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 18The Bank of N.T. Butterfield & Son LimitedNTB | 42.9/100Thin evidence · provisional46% evidence | TURNING | 16.3/35 Income — · PAT — 10% evidence | 13.4/25 ROA — · ROE 4.2% · GNPA — 34% evidence | 5.6/20 P/BV 2.04× · P/BV÷ROE 0.48 70% evidence | 7.6/20 RS sector -1.6% · RS bench 8.6% · 1Y 38%4 of 12 weeks ahead 100% evidence |
| Exact sum: 16.3 + 13.4 + 5.6 + 7.6 = 42.9 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. Financial companies use P/BV÷ROE and asset quality; PEG, industrial OPM and ROCE are excluded. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led S&P 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led S&P 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.
Frequently asked questions
What is The Bank of Nova Scotia's stock price today?
The Bank of Nova Scotia trades at $87.1, +57.2% over the past year. The company is valued at $106 B. The stock sits at 93% of its 52-week range of $57–$89, +15.4% versus its 200-day average. On the tape, the price is in a confirmed uptrend, 65 weeks in. — as of 5 August 2026.
What were The Bank of Nova Scotia's latest quarterly results?
The Bank of Nova Scotia reported total income of $8.6 B and net profit of $2.6 B for the Apr 26 quarter. Income rose 12.2% and profit rose 29.6% year on year. Earnings per share were $2.00. The net margin was 30.5%, 4.1 pp higher than a year earlier. — as of 5 August 2026.
What is The Bank of Nova Scotia's revenue?
The Bank of Nova Scotia reported revenue of $8.6 B in the Apr 26 quarter, +12.2% year on year. For the full FY25 fiscal year, revenue was $33.0 B (+11.5%). Over the last 4 years revenue compounded at 2.9% a year. — as of 5 August 2026.
What is The Bank of Nova Scotia's profit?
The Bank of Nova Scotia earned $2.6 B of net profit in the Apr 26 quarter, +29.6% year on year — the 4th straight quarter of growth. Full-year FY25 profit was $7.8 B. The net margin ran 30.5% in the latest quarter. — as of 5 August 2026.
What is The Bank of Nova Scotia's market cap?
The Bank of Nova Scotia's market capitalisation is $106 B at a stock price of $87.1. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 5 August 2026.
What is The Bank of Nova Scotia's P/BV ratio?
The Bank of Nova Scotia trades at a P/BV of 1.6×, at the 100th percentile of its own 5-year range, against a long-run median of 0.8×. This is a comparison with the stock's own history, not a value call — as of 5 August 2026.
Does The Bank of Nova Scotia pay a dividend?
Yes — The Bank of Nova Scotia declared $1.10 per share for Apr 26, and $4.40 per share across the last four reported quarters. The latest quarter is up 3.8% on the same quarter a year earlier. — as of 5 August 2026.
What is The Bank of Nova Scotia's dividend per share?
The Bank of Nova Scotia's most recently declared dividend is $1.10 per share for Apr 26, giving $4.40 per share over the trailing twelve months. Each figure is the amount declared for that quarter as reported, added across four quarters for the trailing total. — as of 5 August 2026.
What is The Bank of Nova Scotia's dividend yield?
The Bank of Nova Scotia's trailing dividend yield is 5.05%: $4.40 declared per share across the last four reported quarters, against a share price of $87.1. Each quarter’s figure is the amount declared for that quarter as reported, added across four quarters and divided by the latest close. — as of 5 August 2026.
Is The Bank of Nova Scotia overvalued?
On its own history, The Bank of Nova Scotia looks expensive against its own history: its P/BV of 1.6× sits at the 100th percentile of its 5-year range (long-run median 0.8×). That is a percentile read against the stock's own past, not a price opinion or a direction call. — as of 5 August 2026.
Is The Bank of Nova Scotia growing?
Yes — The Bank of Nova Scotia is growing: latest-quarter revenue +12.2% year on year, profit +29.6%, and the the net margin +4.1 pp at 30.5%. The 4-year compound rates are 2.9% (revenue) and −6.0% (profit). The earnings engine currently reads: improving — as of 5 August 2026.
How is The Bank of Nova Scotia performing?
The Bank of Nova Scotia is in a confirmed uptrend, 65 weeks in. Its latest quarter's income rose 12.2% and profit rose 29.6% year on year. Against the S&P 500 it has been ahead on a trailing-13-week view for 10 weeks. This describes what the data did, not a rating. — as of 5 August 2026.
What stage is The Bank of Nova Scotia in?
Mixed — no clean majority across the growth curves, ROE lifting at 10.9% — the per-curve reads carry the story. The read comes from the last 12 quarters of growth (revenue growth +11.5% latest, profit growth +46.1% latest, eps growth +51.4% latest) plus the ROE curve, classified by deterministic rules — a trajectory read, not a buy or sell call — as of 5 August 2026.
Is The Bank of Nova Scotia in an uptrend?
Yes — the price is in a confirmed uptrend (week 65 of stage 2), trading +15.4% versus its 200-day average and at 93% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 5 August 2026.
Is The Bank of Nova Scotia beating the market?
On recent form, yes — The Bank of Nova Scotia has been ahead of the S&P 500 on a trailing-13-week view for 10 straight weeks, the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 10.1 years the stock moved +79% against the S&P 500's +263% — behind the index over the full window. — as of 5 August 2026.
Will The Bank of Nova Scotia's stock price go up?
This page publishes no price forecast for The Bank of Nova Scotia. What it measures instead: the stock price is $87.1, the price is in a confirmed uptrend 65 weeks in. Its P/BV of 1.6× sits at the 100th percentile of its own 5-year range. — as of 5 August 2026.
Is the market betting against The Bank of Nova Scotia?
No — short interest is 0.7% of The Bank of Nova Scotia's tradable float, about 3.5 days to cover at typical volumes. That is a low reading: the crowd is not positioned against this stock. With no quarter-by-quarter holder register here, short interest is the cleanest crowd read we hold — as of 5 August 2026.
Is The Bank of Nova Scotia's loan book healthy?
We do not hold quarterly loan-book quality numbers for The Bank of Nova Scotia, so this page says that plainly. The cleanest available reads are revenue growth (+11.5% in FY25) and the net margin on it (30.5%) — as of 5 August 2026.
Where is The Bank of Nova Scotia in its business cycle?
The Bank of Nova Scotia's FY25 net margin was 23.5%, against a 5-year band of 23.5%–33.9%: the low end of its own band, which is where recoveries start when they come. The latest quarter ran 30.5%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 5 August 2026.
What could break the The Bank of Nova Scotia story?
The sharpest disagreement: the price moved +57.2% in a year while annual EPS moved −3.4% — the difference is re-rating, and re-rating has to be repaid with earnings. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 5 August 2026.
Is The Bank of Nova Scotia a stock worth studying right now?
This is not investment advice. The machine read: The Bank of Nova Scotia's price has outrun its earnings. +57.2% in a year against EPS −3.4% — the market is paying now for delivery later. The sharpest open question: whether earnings grow into a price that has already moved. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 5 August 2026.